PKDCC
Basic information
Region (hg38): 2:42048021-42058517
Links
Phenotypes
GenCC
Source:
- rhizomelic limb shortening with dysmorphic features (Strong), mode of inheritance: AR
- rhizomelic limb shortening with dysmorphic features (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Rhizomelic limb shortening with dysmorphic features | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 30478137 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (178 variants)
- Inborn_genetic_diseases (101 variants)
- Rhizomelic_limb_shortening_with_dysmorphic_features (11 variants)
- PKDCC-related_disorder (5 variants)
- Skeletal_dysplasia (1 variants)
- Abnormality_of_the_skeletal_system (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PKDCC gene is commonly pathogenic or not. These statistics are base on transcript: NM_000138370.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 57 | 65 | ||||
| missense | 136 | 144 | ||||
| nonsense | 3 | |||||
| start loss | 0 | |||||
| frameshift | 10 | 13 | ||||
| splice donor/acceptor (+/-2bp) | 3 | |||||
| Total | 12 | 8 | 138 | 62 | 8 |
Highest pathogenic variant AF is 0.000012408687
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PKDCC | protein_coding | protein_coding | ENST00000294964 | 7 | 10509 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000213 | 0.911 | 125734 | 0 | 13 | 125747 | 0.0000517 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.293 | 233 | 221 | 1.06 | 0.0000128 | 3037 |
| Missense in Polyphen | 59 | 63.768 | 0.92523 | 735 | ||
| Synonymous | -0.333 | 100 | 95.8 | 1.04 | 0.00000565 | 1086 |
| Loss of Function | 1.60 | 10 | 17.1 | 0.584 | 8.27e-7 | 200 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000126 | 0.000119 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000799 | 0.0000791 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000337 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Secreted tyrosine-protein kinase that mediates phosphorylation of extracellular proteins and endogenous proteins in the secretory pathway, which is essential for patterning at organogenesis stages. Mediates phosphorylation of MMP1, MMP13, MMP14, MMP19 and ERP29 (PubMed:25171405). Probably plays a role in platelets: rapidly and quantitatively secreted from platelets in response to stimulation of platelet degranulation (PubMed:25171405). May also have serine/threonine protein kinase activity. Required for longitudinal bone growth through regulation of chondrocyte differentiation. May be indirectly involved in protein transport from the Golgi apparatus to the plasma membrane (By similarity). {ECO:0000250|UniProtKB:Q5RJI4, ECO:0000269|PubMed:25171405}.;
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.229
- ghis
- 0.495
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.231
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pkdcc
- Phenotype
- craniofacial phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; limbs/digits/tail phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype;
Gene ontology
- Biological process
- skeletal system development;protein transport;peptidyl-tyrosine phosphorylation;cell differentiation;bone mineralization;positive regulation of bone mineralization;positive regulation of chondrocyte differentiation;limb morphogenesis;multicellular organism growth;negative regulation of Golgi to plasma membrane protein transport;lung alveolus development;embryonic digestive tract development;roof of mouth development
- Cellular component
- extracellular region;Golgi apparatus
- Molecular function
- protein kinase activity;non-membrane spanning protein tyrosine kinase activity;ATP binding